» Articles » PMID: 35669916

Factors Associated With Neurosyphilis in Patients With Syphilis Treatment Failure: A Retrospective Study of 165 HIV-Negative Patients

Overview
Specialty General Medicine
Date 2022 Jun 7
PMID 35669916
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In recent years, the incidence of syphilis has increased year by year. Our study is to explore the risk factors for the development of neurosyphilis in patients who failed syphilis treatment.

Methods: A total number of 165 patients with complete medical records and who agreed to undergo lumbar puncture were divided into 47 neurosyphilis cases and 118 non-neurosyphilis cases according to the diagnostic criteria of neurosyphilis, and the differences in clinical characteristics and laboratory features between the two groups were analyzed. Significant variables were entered into multivariable logistic regression models.

Results: (1) There were statistical differences ( < 0.05) between the neurosyphilis (NS) group and the non-neurosyphilis (NNS) group in terms of the higher proportion of male and serum rapid plasma reagin (RPR) > 1:32 and the elevated cerebrospinal fluid white blood cell (CSF WBC) and CSF protein in the neurosyphilis group compared with the non-neurosyphilis group. (2) Male gender, serum RPR titers >1:32 at lumbar puncture, CSF WBC >8 × 10/L were significantly associated with neurosyphilis.

Conclusion: For patients who have failed syphilis treatment, lumbar puncture should be performed to exclude neurosyphilis, to enable early diagnosis and treatment, and to prevent irreversible damage of neurosyphilis, especially if the patient is male and has a serum RPR>1:32 and elevated CSF WBC at lumbar puncture, which are risk factors for neurosyphilis.

Citing Articles

Clinical Insights into Neurosyphilis Patients with Leptomeningeal Enhancement of Spinal Cord.

Zhang W, Ma X, Qin K, Kou C, Song C, Xu D Neuropsychiatr Dis Treat. 2024; 20:2541-2552.

PMID: 39717829 PMC: 11663698. DOI: 10.2147/NDT.S492208.


Neurosyphilis: insights into its pathogenesis, susceptibility, diagnosis, treatment, and prevention.

Wu S, Ye F, Wang Y, Li D Front Neurol. 2024; 14:1340321.

PMID: 38274871 PMC: 10808744. DOI: 10.3389/fneur.2023.1340321.

References
1.
Stamm L, Bergen H . A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob Agents Chemother. 2001; 44(3):806-7. PMC: 89774. DOI: 10.1128/AAC.44.3.806-807.2000. View

2.
Chen G, Cao Y, Yao Y, Li M, Tang W, Li J . Syphilis incidence among men who have sex with men in China: results from a meta-analysis. Int J STD AIDS. 2016; 28(2):170-178. PMC: 5026914. DOI: 10.1177/0956462416638224. View

3.
Workowski K, Berman S . Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010; 59(RR-12):1-110. View

4.
Zhou P, Li K, Lu H, Qian Y, Gu X, Gong W . Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai. Sex Transm Dis. 2010; 37(11):726-9. PMC: 3114640. DOI: 10.1097/OLQ.0b013e3181e2c753. View

5.
Lu Y, Ke W, Yang L, Wang Z, Lv P, Gu J . Clinical prediction and diagnosis of neurosyphilis in HIV-negative patients: a case-control study. BMC Infect Dis. 2019; 19(1):1017. PMC: 6886180. DOI: 10.1186/s12879-019-4582-2. View